NCT03843385View on ClinicalTrials.gov

Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis

PHASE3RecruitingINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Ulcerative ColitisInflammatory Bowel Diseases
Interventions
DRUG

encapsulated faecal microbiota filtrate

Multidonor stool mixed with sterile normal saline, homogenized, filtered, centrifuged, air pressure filtered, encapsulated in hypromellose capsules and frozen.

DRUG

encapsulated faecal microbiota

Multidonor stool mixed with sterile normal saline, homogenized, filtered, encapsulated in hypromellose capsules and frozen.

DRUG

Placebo

Sterile saline encapsulated in hypromellose capsules and frozen.

Trial Locations (15)

Unknown

RECRUITING

Jena University Hospital, Jena

RECRUITING

Sozialstiftung Bamberg, Bamberg

RECRUITING

Charité Berlin, Berlin

RECRUITING

DRK Kliniken Berlin Westend, Berlin

RECRUITING

Krankenhaus Waldfriede, Berlin

RECRUITING

Universitätsklinikum Carl Gustav Carus Dresden, Dresden

RECRUITING

FAU Universität Erlangen-Nürnberg, Erlangen

RECRUITING

Agaplesion Markus Krankenhaus, Frankfurt

RECRUITING

Universitätsklinik Freiburg, Freiburg im Breisgau

RECRUITING

Klinikum Fulda, Fulda

RECRUITING

Universitätsklinikum Halle (Saale), Halle

RECRUITING

Universitätsklinikum Schleswig Holstein, Kiel

RECRUITING

Gesellschaft Klinische Studien Leipzig, Leipzig

RECRUITING

Städtisches Klinikum Lüneburg, Lüneburg

RECRUITING

Universitätsklinikum Ulm, Ulm

All Listed Sponsors
collaborator

German Federal Ministry of Education and Research

OTHER_GOV

lead

Andreas Stallmach

OTHER